Clinical Trial Update: Terazosin and Parkinson's Disease Extension Study [Phase 2]

View source ↗

Summary

This clinical trial update covers a Phase 2 extension study of terazosin for symptomatic Parkinson's disease and REM sleep behavior disorder, which is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease
• Prodromal Parkinson Disease
• Rem Sleep Behavior Disorder

Drugs mentioned

• Terazosin (terazosin)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Symptomatic Parkinson Disease, REM Sleep Behavior Disorder | Phase 2 | Status: ACTIVE_NOT_RECRUITING